Amal El Beshlawy
Prof. Dr. Pediatric Hematology
(email)
Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia
View
What links here
Citation:
El-Beshlawy, A., "Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia", Haematologica, vol. 106, issue 9, pp. 2489-2492, 2021.
Export
RTF
Tagged
XML
BibTex
Google Scholar
Preview
Attachment
Size
10251-article_text-75083-2-10-20210830_2.pdf
1.22 MB
Bio
Professor Amal El-Beshlawy CV
Publications
Short CV
Recent Publications
Deferiprone versus deferoxamine for transfusional iron overload in sickle cell disease and other anemias: Pediatric subgroup analysis of the randomized, open-label FIRST study.
Management of transfusion-dependent β-thalassemia (TDT): Expert insights and practical overview from the Middle East.
Magnitude of cumulative iron overload correlates with the severity of anemia in untreated non-transfusion-dependent β-thalassemia.
Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years.
Egyptian Gaucher disease type 3 patients: a large cohort study spanning two decades (journal article)
more
Tourism